318 related articles for article (PubMed ID: 25132320)
1. Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions.
Kropff J; Bruttomesso D; Doll W; Farret A; Galasso S; Luijf YM; Mader JK; Place J; Boscari F; Pieber TR; Renard E; DeVries JH
Diabetes Obes Metab; 2015 Apr; 17(4):343-9. PubMed ID: 25132320
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison.
Luijf YM; Mader JK; Doll W; Pieber T; Farret A; Place J; Renard E; Bruttomesso D; Filippi A; Avogaro A; Arnolds S; Benesch C; Heinemann L; DeVries JH;
Diabetes Technol Ther; 2013 Aug; 15(8):722-7. PubMed ID: 23650900
[TBL] [Abstract][Full Text] [Related]
3. FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions.
Boscari F; Galasso S; Facchinetti A; Marescotti MC; Vallone V; Amato AML; Avogaro A; Bruttomesso D
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):180-186. PubMed ID: 29258716
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes.
Aberer F; Hajnsek M; Rumpler M; Zenz S; Baumann PM; Elsayed H; Puffing A; Treiber G; Pieber TR; Sourij H; Mader JK
Diabetes Obes Metab; 2017 Jul; 19(7):1051-1055. PubMed ID: 28205324
[TBL] [Abstract][Full Text] [Related]
5. A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes.
Matuleviciene V; Joseph JI; Andelin M; Hirsch IB; Attvall S; Pivodic A; Dahlqvist S; Klonoff D; Haraldsson B; Lind M
Diabetes Technol Ther; 2014 Nov; 16(11):759-67. PubMed ID: 25233297
[TBL] [Abstract][Full Text] [Related]
6. A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system.
Christiansen M; Bailey T; Watkins E; Liljenquist D; Price D; Nakamura K; Boock R; Peyser T
Diabetes Technol Ther; 2013 Oct; 15(10):881-8. PubMed ID: 23777402
[TBL] [Abstract][Full Text] [Related]
7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes.
Bonora B; Maran A; Ciciliot S; Avogaro A; Fadini GP
J Endocrinol Invest; 2016 Dec; 39(12):1391-1399. PubMed ID: 27287421
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
[TBL] [Abstract][Full Text] [Related]
10. Toward Calibration-Free Continuous Glucose Monitoring Sensors: Bayesian Calibration Approach Applied to Next-Generation Dexcom Technology.
Acciaroli G; Vettoretti M; Facchinetti A; Sparacino G
Diabetes Technol Ther; 2018 Jan; 20(1):59-67. PubMed ID: 29265916
[TBL] [Abstract][Full Text] [Related]
11. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
12. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
[TBL] [Abstract][Full Text] [Related]
13. Performance evaluation of a continuous glucose monitoring system under conditions similar to daily life.
Pleus S; Schmid C; Link M; Zschornack E; Klötzer HM; Haug C; Freckmann G
J Diabetes Sci Technol; 2013 Jul; 7(4):833-41. PubMed ID: 23911164
[TBL] [Abstract][Full Text] [Related]
14. A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot.
Moser O; Pandis M; Aberer F; Kojzar H; Hochfellner D; Elsayed H; Motschnig M; Augustin T; Kreuzer P; Pieber TR; Sourij H; Mader JK
Diabetes Obes Metab; 2019 Apr; 21(4):1043-1048. PubMed ID: 30484947
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of the Enlite 6-day glucose sensor with guardian and Veo calibration algorithms.
Keenan DB; Mastrototaro JJ; Zisser H; Cooper KA; Raghavendhar G; Lee SW; Yusi J; Bailey TS; Brazg RL; Shah RV
Diabetes Technol Ther; 2012 Mar; 14(3):225-31. PubMed ID: 22145851
[TBL] [Abstract][Full Text] [Related]
17. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
[TBL] [Abstract][Full Text] [Related]
18. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
19. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
[No Abstract] [Full Text] [Related]
20. Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical Trials.
Jensen MH; Dethlefsen C; Hejlesen O; Vestergaard P
J Diabetes Sci Technol; 2020 Nov; 14(6):1074-1078. PubMed ID: 31096765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
